Search Within

Derek B Sant'angelo

Refine Results
Formats
  1. Journal Article (33)
  2. Meeting Abstract (13)
Groups
  1. Sloan Kettering Institute Faculty (13)
  2. Molecular Pharmacology and Chemistry Program Faculty (11)
  3. Center for Hematologic Malignancies (8)
  4. Hematologic Malignancies Research (8)
  5. Adult Bone Marrow Transplant (BMT) Service (7)
  6. Gerstner Sloan Kettering Graduate School of Biomedical Sciences (7)

More Groups

People
  1. Michel Sadelain (11)
  2. Damian Kovalovsky (8)
  3. Lisa Denzin (8)
  4. Amanda Holland (7)
  5. Eric Alonzo (7)
  6. Robert Jenq (7)

More People

Years
  1. 2013 (1)
  2. 2011 (8)
  3. 2010 (8)
  4. 2009 (1)
  5. 2008 (5)
  6. 2007 (2)

More Years

Publications
  1. Journal of Immunology (9)
  2. FASEB Journal (5)
  3. PLoS ONE (5)
  4. Proceedings of the National Academy of Sciences of the United States of America (4)
  5. Blood (3)
  6. European Journal of Immunology (3)

More Publications

Publishers
  1. The American Association of Immunologists, Inc (9)
  2. Federation of American Societies for Experimental Biology (5)
  3. Public Library of Science (5)
  4. Elsevier Inc. (4)
  5. National Academy of Sciences (4)
  6. American Society of Hematology (3)

More Publishers

Results (46)

Export to EndNote | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating GVHD
    Journal Article

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N. L.; Rao, U. K.; Young, L. F.; West, M. L.; Singer, N. V.; Lee, H.; Na, I. K.; more...
    Cancer Research (2013)

    Fulltext@MSK | Save
  • Genetically engineered allogeneic T Cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Cancer Research (2011)

    Fulltext@MSK | Save
  • The Paf oncogene is essential for hematopoietic stem cell function and development
    Journal Article

    Amrani, Y. M.; Gill, J.; Matevossian, A.; Alonzo, E. S.; Yang, C.; Shieh, J.H.; Moore, M. A.; Park, C. Y.; Sant'angelo, D. B.; Denzin, L. K.
    Journal of Experimental Medicine (2011)

    Fulltext@MSK | Save
  • The BTB-ZF family of transcription factors: Key regulators of lineage commitment and effector function development in the immune system
    Journal Article

    Beaulieu, A. M.; Sant'angelo, D. B.
    Journal of Immunology (2011)

    Fulltext@MSK | Save
  • Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient
    Journal Article

    Eidson, M.; Wahlstrom, J.; Beaulieu, A. M.; Zaidi, B.; Carsons, S. E.; Crow, P. K.; Yuan, J.; Wolchok, J. D.; Horsthemke, B.; Wieczorek, D.; more...
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Genetically engineered donor T cells for BMT immunotherapy: Expression of trail and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J. J.; more...
    Biology of Blood and Marrow Transplantation (2011)

    Fulltext@MSK | Save
  • TCR affinity for self-ligands influences the development and function of encephalitogenic T cells
    Journal Article

    Li, J.; Vandal, O.; Sant'angelo, D. B.
    PLoS ONE (2011)

    Fulltext@MSK | Save
  • Requirements for eomesodermin and promyelocytic leukemia zinc finger in the development of innate-like CD8+ T cells
    Journal Article

    Gordon, S. M.; Carty, S. A.; Kim, J. S.; Zou, T.; Smith-Garvin, J.; Alonzo, E. S.; Haimm, E.; Sant'angelo, D. B.; Koretzky, G. A.; Reiner, S. L.; more...
    Journal of Immunology (2011)

    Fulltext@MSK | Save
  • Development of PLZF-expressing innate T cells
    Journal Article

    Alonzo, E. S.; Sant'angelo, D. B.
    Current Opinion in Immunology (2011)

    Fulltext@MSK | Save
  • Genetic engineering of donor T cells for BMT immunotherapy: Expression of TRAIL and PLZF selectively enhances GVT and abrogates GVHD
    Meeting Abstract

    Ghosh, A.; Holland, A. M.; Dogan, Y.; Yim, N.; Rao, U. K.; Young, L. F.; Smith, O. M.; Jenq, R.; Na, I. K.; Tsai, J.; more...
    Blood (2010)

    Fulltext@MSK | Save